Oxford BioTherapeutics Ltd
Oxford BioTherapeutics Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2025-09-16 | NCT04064359 |